ABFERO LIMITED

Company number 11255897

Date	Type	Description	View / Download
17 Apr 2024	CS01	Confirmation statement made on 4 April 2024 with no updates	(3 pages)
17 Apr 2024	PSC07	Cessation of Abfero Pharmaceuticals, Inc as a person with significant control on 16 April 2024	(1 page)
17 Apr 2024	PSC01	Notification of Tobias Sidelmann Christensen as a person with significant control on 16 April 2024	(2 pages)
02 Nov 2023	AA	Unaudited abridged accounts made up to 30 April 2023	(8 pages) Download iXBRL
11 Apr 2023	CS01	Confirmation statement made on 4 April 2023 with no updates	(3 pages)
14 Mar 2023	CS01	Confirmation statement made on 4 April 2022 with no updates	(3 pages)
04 Aug 2022	AA	Unaudited abridged accounts made up to 30 April 2022	(8 pages) Download iXBRL
28 Mar 2022	CS01	Confirmation statement made on 13 March 2022 with no updates	(3 pages)
04 Jan 2022	AA01	Current accounting period extended from 31 December 2021 to 30 April 2022	(1 page)
13 Dec 2021	AP01	Appointment of Mr Robert Guglielmetti as a director on 10 December 2021	(2 pages)
10 Dec 2021	TM01	Termination of appointment of Thomas Xavier Neenan as a director on 10 December 2021	(1 page)
10 Dec 2021	TM01	Termination of appointment of Michael Geoffrey Penington as a director on 10 December 2021	(1 page)
10 Dec 2021	TM01	Termination of appointment of Steven Keith Burke as a director on 10 December 2021	(1 page)
10 Dec 2021	AD01	Registered office address changed from Longwall Venture Partners, Quad One Becquerel Avenue Harwell Didcot Oxon OX11 0RA United Kingdom to The White Building 6th Floor 33 Kings Road Reading Berkshire RG1 3AR on 10 December 2021	(1 page)
01 Oct 2021	AA	Total exemption full accounts made up to 31 December 2020	(6 pages) Download iXBRL
18 Jun 2021	AA01	Previous accounting period shortened from 31 March 2021 to 31 December 2020	(1 page)
25 Mar 2021	AA	Total exemption full accounts made up to 31 March 2020	(6 pages) Download iXBRL
16 Mar 2021	CS01	Confirmation statement made on 13 March 2021 with no updates	(3 pages)
18 Mar 2020	CS01	Confirmation statement made on 13 March 2020 with no updates	(3 pages)
09 Dec 2019	AA	Unaudited abridged accounts made up to 31 March 2019	(9 pages) Download iXBRL
21 Jul 2019	AP01	Appointment of Michael Geoffrey Penington as a director on 10 July 2019	(2 pages)
28 Mar 2019	CS01	Confirmation statement made on 13 March 2019 with no updates	(3 pages)
05 Jun 2018	AD01	Registered office address changed from Electron Building, Fermi Avenue Harwell Science & Innovation Centre Didcot Oxfordshire OX11 0QR United Kingdom to Longwall Venture Partners, Quad One Becquerel Avenue Harwell Didcot Oxon OX11 0RA on 5 June 2018	(1 page)
14 Mar 2018	NEWINC	Incorporation MODEL ARTICLES ‐ Model articles adopted (Amended Provisions) Statement of capital on 2018-03-14 GBP 1	(24 pages)